CSS
FULC icon

Cubist Systematic Strategies’s Fulcrum Therapeutics FULC Stock Holding History

Cubist Systematic Strategies’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57,070
Closed -$164K – 3165
2025
Q1 		$164K Buy
+57,070
New +$210K ﹤0.01% 2558
2024
Q2 		– Sell
-171,507
Closed -$1.62M – 3337
2024
Q1 		$1.62M Buy
+171,507
New +$1.53M 0.01% 1808
2023
Q2 		– Sell
-65,076
Closed -$185K – 3790
2023
Q1 		$185K Buy
65,076
+34,374
+112% +$308K ﹤0.01% 3263
2022
Q4 		$224K Sell
30,702
-5,839
-16% -$38.1K ﹤0.01% 3519
2022
Q3 		$296K Sell
36,541
-216,513
-86% -$1.55M ﹤0.01% 3526
2022
Q2 		$1.24M Buy
253,054
+242,167
+2,224% +$2.37M 0.01% 2289
2022
Q1 		$257K Sell
10,887
-14,037
-56% -$199K ﹤0.01% 2926
2021
Q4 		$441K Sell
24,924
-5,574
-18% -$110K ﹤0.01% 2534
2021
Q3 		$860K Buy
30,498
+27,703
+991% +$525K 0.01% 1639
2021
Q2 		$29K Sell
2,795
-860
-24% -$8.69K ﹤0.01% 2832
2021
Q1 		$43K Buy
3,655
+3,110
+571% +$38.5K ﹤0.01% 2740
2020
Q4 		$6K Buy
+545
New +$6.16K ﹤0.01% 2523
2020
Q3 		– Sell
-200
Closed -$4K – 2534
2020
Q2 		$4K Buy
+200
New +$3.15K ﹤0.01% 2351

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's FULC Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Fulcrum Therapeutics (FULC) in Q2 2025, closing a stake of 57,070 shares — an estimated $164K sold.

Cubist Systematic Strategies first reported a position in FULC in Q2 2020 and held it in 13 quarters. The position peaked at $1.62M in Q1 2024. 122 funds tracked by Wall St. Rank hold FULC as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Fulcrum Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 57,070 Fulcrum Therapeutics shares in Q2 2025, an estimated $164K.
  • Cubist Systematic Strategies first reported a position in Fulcrum Therapeutics in Q2 2020 and held it in 13 quarters.
  • Cubist Systematic Strategies's Fulcrum Therapeutics position peaked at $1.62M in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.